Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
Crossref DOI link: https://doi.org/10.1371/journal.pntd.0005361
Published Online: 2017-02-03
Update policy: https://doi.org/10.1371/journal.pntd.corrections_policy
Laustsen, Andreas H. http://orcid.org/0000-0001-6918-5574
Johansen, Kristoffer H.
Engmark, Mikael
Andersen, Mikael R.
Funding for this research was provided by:
Novo Nordisk Foundation (NNF13OC0005613)
Novo Nordisk Foundation (NNF16OC0019248)
Version of Record valid from 2017-02-03